Trans TRT journeys on TikTok: hype vs. clinical reality

What did @tommiefjones actually say?

Tommie is transitioning from estrogen injections to estrogen patches and marking the moment by physically collecting roughly 25 used syringes before disposal. The core claim here is personal and experiential: that self-injecting estrogen is painful, that patches are a less painful method, and that the whole process carries emotional weight. There is no dosing advice, no medical claim about superiority, and no miracle promises. What you are watching is someone processing a medication change, not delivering a health lecture.

That said, the framing that patches are simply the "less painful method" does carry an implicit assumption worth examining: that patches and injections are clinically interchangeable and that switching is uncomplicated. That assumption is where the nuance lives.

Does the science back this up?

The switch from injections to patches for gender-affirming estrogen therapy is medically legitimate and well-documented. But the two delivery methods are not identical in how they behave in the body, and calling patches simply "easier" glosses over real pharmacokinetic differences that patients and clinicians should understand before switching.

Estradiol injections, typically estradiol valerate or cypionate, produce sharp peaks in serum estradiol followed by a gradual trough. Patches deliver estradiol transdermally at a more stable rate, bypassing first-pass hepatic metabolism. A 2021 review by Iwamoto et al. in Transgender Health found that transdermal estradiol is associated with a more stable serum estradiol level and a potentially lower risk of venous thromboembolism compared to oral estrogens. The injection-versus-patch comparison on VTE risk is less settled, but the stability argument for patches is real.

Adherence is also a factor. A patch must be changed on a consistent schedule, typically every three to four days, and skin site rotation matters. Missing a patch change can cause hormone levels to drop in ways that feel abrupt. That is not nothing.

What did they get wrong (or right)?

Tommie gets credit for not overclaiming. There is no assertion that patches are medically superior, no dosing guidance, and no dismissal of medical oversight. The emotional framing, "with beauty comes pain," is personal testimony, not medical advice, and it is fair to treat it as such.

Where the video is incomplete, not wrong exactly, is in the suggestion that switching delivery methods is straightforwardly a comfort upgrade. In practice, some patients find that their hormone levels respond differently to transdermal delivery than to injections, and achieving equivalent serum estradiol levels may require dose adjustments confirmed through bloodwork. The Endocrine Society's 2017 clinical practice guidelines (Hembree et al., Journal of Clinical Endocrinology and Metabolism) explicitly recommend monitoring serum estradiol levels when changing formulations.

The tattoo analogy is colorful and emotionally resonant for the audience, but it is not a clinical parallel. Tattoo pain is acute and finite. Injection schedules are ongoing and require sterile technique. Conflating them could subtly minimize the real skill and care that safe self-injection requires.

What should you actually know?

If you are considering switching from estrogen injections to patches, or any delivery method change, here is what the evidence actually supports.

• Serum estradiol levels should be checked after switching formulations, not assumed to be equivalent. Different routes of administration absorb differently across individuals.
• Transdermal estradiol avoids first-pass liver metabolism, which is one reason some clinicians prefer it over oral estrogens, particularly for patients with cardiovascular risk factors (Scarabin et al., 2003, Thrombosis and Haemostasis).
• Injection-related VTE risk compared to transdermal patches is less clearly established in transgender women specifically. The research base is growing but still limited in sample size.
• Patch adhesion failure is a real-world problem. Humidity, skin oils, and placement location all affect how well patches stay on and how consistently hormone is delivered.
• Disposal of used syringes should follow sharps disposal guidelines in your jurisdiction. Tommie is right to dispose of them properly rather than tossing them in household trash.

Is this video harmful or helpful?

Mostly helpful, with caveats. The video normalizes the realities of gender-affirming hormone therapy in a way that is humanizing and non-sensational. It does not spread misinformation about hormone therapy, does not discourage medical oversight, and does not make therapeutic claims it cannot back up.

The gap is that a viewer who has not had a conversation with a prescribing clinician might take away the idea that switching from shots to patches is a self-directed decision with no clinical coordination needed. It is not. A formulation change should involve a provider, a follow-up lab draw, and a clear plan for monitoring. The emotional journey is real and worth documenting. The medical logistics still require professional involvement.